Novarad AR System For HoloLens Cleared By FDA For Medical Use

Novarad’s OpenSight Augmented Reality System is the first AR medical solution for Microsoft HoloLens cleared by the FDA receiving 510(k) clearance for use in pre-operative surgical planning.

Recently, Novarad’s OpenSight Augmented Reality System - the first AR medical solution for Microsoft HoloLens, has been cleared by the FDA receiving 510(k) clearance for use in pre-operative surgical planning.
 
The technology renders 3D images of patients interactively, while accurately overlaying them directly onto the patient’s body. The OpenSight System together with virtual tool technology and an integrated targeting system, enables doctors to see the patient and into the patient simultaneously to more accurately plan surgery.
 
This is transformative technology that will unite preoperative imaging with augmented reality to improve the precision, speed, and safety of medical procedures, This internal visualization can now be achieved without the surgeon ever making an incision, improving outcomes in a world of more precise medicine,” explained Dr. Wendell Gibby, Novarad CEO and co-creator of OpenSight.
 
Source: OpenSight
 
OpenSight utilizing the Microsoft HoloLens headset enables doctors to see the 3D images of patients in augmented reality while also allowing to see the patient (reality) at the same time. Augmented reality also allows you see your complete real-world surroundings, avoiding the disorientation of virtual reality.
 
According to the company, multiple headsets will allow many users to see the same anatomy at the same time, allowing for the training of less experienced personnels. The company have also developed a teaching version of the software that lets medical students perform virtual dissections on medical cadavers.
 
Novarad has been working in medical imaging since 1998, offering a customizable workflow and imaging solutions, which it hopes to continue into the new frontier of immersive technology.
 
For further information, you can visit the Novarad website.